AbbVie
ABBV
ABBV
1,650 hedge funds and large institutions have $69.4B invested in AbbVie in 2016 Q3 according to their latest regulatory filings, with 102 funds opening new positions, 630 increasing their positions, 661 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
5% less repeat investments, than reductions
Existing positions increased: 630 | Existing positions reduced: 661
14% less funds holding in top 10
Funds holding in top 10: 94 → 81 (-13)
15% less call options, than puts
Call options by funds: $636M | Put options by funds: $751M
Holders
1,650
Holding in Top 10
81
Calls
$636M
Puts
$751M
Top Buyers
| 1 | +$539M | |
| 2 | +$210M | |
| 3 | +$127M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$104M |
| 5 |
State Street
Boston,
Massachusetts
|
+$98.7M |
Top Sellers
| 1 | -$748M | |
| 2 | -$427M | |
| 3 | -$405M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$210M |
| 5 |
O
OrbiMed
New York
|
-$148M |